Executives
Shai Novik
Executive Chairman
Oren Hershkovitz
Ph.D., CEO
Shachar Shlosberger
CFO
Board
Dr. Brian Schwartz
MD, Director
Sangwoo Lee
Director
Abraham Havron
Ph.D, Director
Bernhard Kirschbaum
Ph.D, Director
Michel Habib
Director
Gili Hart
Ph.D, Director

About ENLIVEX

As a clinical:stage company focused on macrophage reprogramming, we intend to develop and commercialize a drug pipeline for macrophage reprogramming in solid cancers, Sepsis and other indications. Our pioneering Allocetra™ cell:based therapy breaks with old paradigms, offering to effectively treat numerous acute conditions through a radically different clinical approach.